News

Article

Psychedelics Beyond Clinical Settings Poll

Author(s):

Psychiatric Times Editors

Answer a quick question on psychedelics!

Have your patients shared or expressed interest in psychedelics for therapeutic purposes outside of clinical settings?

Yes, patient(s) have shared their interest
No, patient(s) have not talked about it
Related Videos
Jorm Sangsorn/AdobeStock
RolfImages/AdobeStock
CravenA/AdobeStock
brain
Related Content
Ronstik/AdobeStock
February 14th 2025

Week in Review: February 10-14

Megan McSweeney
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
Pakin/Adobe Stock
December 31st 2024

ACNP Attendees Reflect on 2024 and Look Forward to 2025

Megan McSweeney
David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders
April 6th 2021

David Hellerstein, MD: Psychedelic Treatments for Psychiatric Disorders

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
depression
December 18th 2024

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results

Leah Kuntz
MindMed Reaches Phase 3 in Study of Psychedelic MM120 for Generalized Anxiety Disorder
December 17th 2024

MindMed Reaches Phase 3 in Study of Psychedelic MM120 for Generalized Anxiety Disorder

Daniel R. Karlin, MD, MA
© 2025 MJH Life Sciences

All rights reserved.